Evaluating the Comparative Efficacy between Ivabradine and Beta Blockers in Indian Acute Coronary Syndrome Patients | Chapter 4 | Current Overview on Pharmaceutical Science Vol. 5

 The basic aim concerning this study search out evaluate the tolerability and efficiency middle from two points ivabradine and testing-blockers in severe heart failure disease (ACS) patients accompanying decreased expulsion part and still evaluate the contraindications for beta-blockers. A six-period anticipated practical research was completed activity. The study state contains 100 patients at which point Group A-50 and Group B-50. The cases were preferred established addition and expulsion criteria. The New York Heart Association (NYHA) Classification was used to categorise the victims established their manifestations of common respiring and variable degrees of inability of whiff. The plurality of the cases were very troubled in group of same status between 55-64 (32%) age adult. The predominance of ACS was extreme in Rural (56%). Both drugs displayed decrease in the mean courage rate from 112.98±23.90 to 89.97±10.27 beats per minute in Group A and 99.6±20.44 to 86.76±13.14 beats per minute gang B (P=0.24). The judgments were clinically and statistically important, accompanying a standard P-worth (P>0.05). Ivabradine is as active as beta-blockers, but it has existed clinically proved to lower soul rate accompanying no negative inotropism.

Author(s) Details:

Pradeep Battula,
Department of Pharmacy Practice, Santhiram college of Pharmacy, Nandyal, Andhra Pradesh, India.

B. Prathima Reddy,
Department of Pharmacy Practice, Creative Educational Society’s College of Pharmacy, Kurnool, Andhra Pradesh, India.

L. Poonam,
Department of Pharmacy Practice, Creative Educational Society’s College of Pharmacy, Kurnool, Andhra Pradesh, India.

L. Hemanth Kumar,
Department of Pharmacy Practice, Creative Educational Society’s College of Pharmacy, Kurnool, Andhra Pradesh, India.

N. Dimpu Sri,
Department of Pharmacy Practice, Creative Educational Society’s College of Pharmacy, Kurnool, Andhra Pradesh, India.

Kali Chandra Shekar,
Department of General Medicine, Government Medical College, Machilipatnam, Andhra Pradesh, India.

Please see the link here: https://stm.bookpi.org/COPS-V5/article/view/9452

Safety and Efficacy of Selective Anti-Hypertensive Drugs in Patients with Cardiovascular Diseases: An Observational Study| Chapter 2 | Current Overview on Pharmaceutical Science Vol. 4

 The study was transported to determine the the most prudent and most effective drug among differing categories of antagonistic-hypertensive drugs to treat hypertension in patients accompanying various cardiovascular afflictions. Hypertension is a condition with persistent promotion of Blood Pressure in arteries. It is the second superior cause of death. The complex interplay of genes and environmental determinants results in hypertension. Severe headache, drowsiness, view problems, nosebleed, fatigue, and disorientation are among the syndromes. It can cause a variety of cardiovascular questions, including myocardial infarction, heart failure artery ailment, and heart failure. The situation of Hypertension can be done by Anti-Hypertensive Drugs that include Angiotensin-II Receptor Blockers, Beta Blockers, Angiotensin Converting Enzyme Inhibitors, etc. The study complicated a sample size of 220 at a distance which 100 were Myocardial Infarction subjects,100 were coronary artery ailment patients and 20 were Heart Failure cases. Angiotensin-II Receptor Blockers, Beta Blockers, and Angiotensin Converting Enzyme Inhibitors were the antihypertensive drugs chosen for the study. Angiotensin-II Receptor Blockers were recommended to 31 Myocardial Infarction patients, 31 heart failure artery disease subjects, and 8 Heart Failure patients. Beta Blockers were arbitrary to 58 patients accompanying myocardial infarction, 58 victims with coronary channel disease, and 7 victims with heart attack. Angiotensin Converting.Enzyme Inhibitors were prescribed to 10 Myocardial Infarction patients,10 Coronary Artery Disease sufferers, and 5 Heart Failure patients. The study disclosed an outcome at which point Beta Blockers were observed expected the drugs with maximum efficacy and maximum security.

Author(s) Details:

R. E. Ugandar,
Department of Pharmacy Practice, Santhiram College of Pharmacy, Nandyal-518501, Kurnool District, Andhra Pradesh, India.

Umadevi Iluru,
Department of Neurology, Santhiram Medical College and General Hospital, NH-40, Venkateswarapuram-518112, Panyam (M), Nandyal District, Andhra Pradesh, India.

Mariamma Bethe,
Department of Critical Care Medicine, Santhiram Medical College and General Hospital, NH-40, Venkateswarapuram-518112, Panyam (M), Nandyal District, Andhra Pradesh, India.

C. Bhargava Reddy,
Department of Pharmacy Practice, Santhiram College of Pharmacy, Nandyal-518501, Kurnool District, Andhra Pradesh, India.

A. Sai Keshava Reddy,
Department of Pharmacy Practice, Santhiram College of Pharmacy, Nandyal-518501, Kurnool District, Andhra Pradesh, India.

Kiran C. Nilugal,
School of Pharmacy, Management and Science University Shah Alam. Malaysia.

Nagashekhara Molugulu,
School of Pharmacy, Monash University, Jalan Lagoon Selatan, Bandar Sunway, 47500 Subang Jaya, Selangor, Malaysia.

Venkata Ramana Baru,
Department of Pharmacy Practice, Santhiram College of Pharmacy, Nandyal-518501, Kurnool District, Andhra Pradesh, India.

K. Anusha,
Department of Pharmacy Practice, Santhiram College of Pharmacy, Nandyal-518501, Kurnool District, Andhra Pradesh, India.

Please see the link here: https://stm.bookpi.org/COPS-V4/article/view/9304